Drugs / PRO131921
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00496132 | Aug 2007 → Jun 2009 | B-cell chronic lymphocytic leukemia | Genentech, Inc. | Terminated | No outcome recorded |
| Phase 1/2 | NCT00452127 | May 2007 → May 2009 | non-Hodgkin lymphoma | Genentech, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO131921 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00452127 ↗ |
| Route | Intravenous | “Escalating doses by IV infusion” NCT00452127 ↗ |